Cervical cancer is the most prevalent gynecologic malignancy, especially in women of low-
and middle-income countries (LMICs). With a better understanding of the etiology and …

Objective Testing for high risk human papillomavirus (HR-HPV) is increasing; however due
to limitations in specificity there remains a need for better triage tests. Research efforts have …

Objective triage strategies are required to prevent unnecessary referrals for colposcopy in
population‐based screening programs using primary high‐risk human papillomavirus …

Primary screening for high-risk human papillomavirus (hrHPV) requires a triage protocol.
Repeat cytology testing at baseline and after 6 to 12 months has emerged as a reasonable …

Objectives Methylation marker analysis using bi-marker panel MAL/miR-124-2 is a
promising triage test for identifying cervical (pre) cancer in high-risk human papillomavirus …

Cervical neoplasia‐specific biomarkers, eg DNA methylation markers, with high sensitivity
and specificity are urgently needed to improve current population‐based screening on (pre) …

Aim: To evaluate the triage performance of six host-cell DNA methylation markers derived
from two genome-wide discovery screens for detection of cervical precancer (cervical …

Background To conduct a meta-analysis of performance of DNA methylation in women with
high-grade cervical intraepithelial neoplasia (CIN2+). Methods Medline and Embase …

Cervical cancer remains a health concern. Effective screening programs are critical to
reduce the incidence and mortality. High‐risk HPV (hr‐HPV) testing as primary screening …

Background: The aim of this systematic review and meta-analysis was to assess the
evidence for the diagnostic effectiveness of human papillomavirus (HPV) methylation …